{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-087237","form_type":"8-K","ticker":null,"cik":"0001117480","company_name":"CHIMERIX INC","filed_at":"2025-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.572259+00:00","generated_at":"2026-05-23T09:58:54.872976+00:00","sec_items":["1.02","2.01","3.01","3.03","5.01","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Jazz Pharmaceuticals completes $8.55/share acquisition of Chimerix; 90.45% of shares tendered","bullets":["Offer expired April 17, 2025; 84,845,016 shares validly tendered (~90.45% outstanding).","Purchaser merged into Chimerix on April 21, 2025; Chimerix becomes indirect wholly owned subsidiary of Jazz.","All pre-merger directors resigned; Alan Campion named sole director and CFO; Andrea Burke VP.","Company notified Nasdaq of delisting; intends to file Form 15 to terminate SEC reporting obligations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-087237","json":"https://secwatch.observer/filing/0001193125-25-087237.json","markdown":"https://secwatch.observer/filing/0001193125-25-087237.md","text":"https://secwatch.observer/filing/0001193125-25-087237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/d942664d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:58:54.872976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a54c565c6","claim":"Andrea Burke was appointed as Vice President at CHIMERIX INC.","evidence_excerpt":"the officers of the Company are as follows: Alan Campion, Chief Financial Officer, and Andrea Burke, Vice President.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President"}],"fact_type":"executive_change"},{"claim_id":"4fdeff19a4","claim":"Lisa L. Decker resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"62ab98cca6","claim":"Pratik S. Multani resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6c172de162","claim":"Martha J. Demski resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7ce1ba15b8","claim":"Fred. A. Middleton resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9b868cde14","claim":"Robert J. Meyer resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a75e51bdec","claim":"Mike Sherman resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a9c0d4447a","claim":"Vicki Vakiener resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b702dc96ea","claim":"Alan Campion was appointed as Sole Director at CHIMERIX INC.","evidence_excerpt":"Alan Campion, the sole director of the Purchaser immediately prior to the Effective Time, became the sole director of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"became"},{"label":"Role","value":"Sole Director"}],"fact_type":"executive_change"},{"claim_id":"cb802b96ce","claim":"Marc D. Kozin resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e934809e56","claim":"Michael T. Andriole resigned as Director at CHIMERIX INC.","evidence_excerpt":"each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fe1c7cc003","claim":"Alan Campion was appointed as Chief Financial Officer at CHIMERIX INC.","evidence_excerpt":"the officers of the Company are as follows: Alan Campion, Chief Financial Officer, and Andrea Burke, Vice President.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"43b2c002cc952a970136de33b67821c0ee4e91e1","claim":"CHIMERIX INC: Amendments to articles of incorporation and bylaws pursuant to a merger; certificate and bylaws amended and restated in their entirety.","evidence_excerpt":"Pursuant to the terms of the Merger Agreement, at the Effective Time, the Company’s certificate of incorporation and bylaws were each amended and restated in their entirety.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"}],"fact_type":"governance_change"},{"claim_id":"7a7b6a8a0d7f7ef0603738e2e1c9553766aae178","claim":"CHIMERIX INC underwent a change of control involving Jazz Pharmaceuticals Public Limited Company for $8.55 per share in cash (closed 2025-04-21).","evidence_excerpt":"a tender offer (the “Offer”) to purchase all of the issued and outstanding shares of the common stock of the Company, par value $0.001 per share (the “Shares”), in exchange for $8.55 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the “Offer Consideration”). The Offer expired as","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1117480/000119312525087237/0001193125-25-087237-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Jazz Pharmaceuticals Public Limited Company"},{"label":"Consideration","value":"$8.55 per share in cash"},{"label":"Closing","value":"2025-04-21"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}